Share this page!

Kai Kupferschmidt Profile picture
Twitter logo
19 Dec, 4 tweets, 4 min read
Meine Kollegen vom @pandemiapodcast und ich haben viele Fragen bekommen in den vergangenen Wochen zu den neuen Impstoffen, zu ihrer schnellen Entwicklung, ihrer Sicherheit, zu Impfbereitschaft und Impfpflicht. Wir wollten das natürlich aufnehmen.
@pandemiapodcast Die neue Folge ist darum ein etwas wilder Ritt querfeldein und wir binden zusammen, worüber wir in den ersten Folgen der zweiten Staffel gesprochen haben: Impfstoffe, Pocken, Masern und eben #SARSCoV2. Die Folge gibt es hier: viertausendhertz.de/pan16/
Als Nächstes dann Gelbfieber!
@pandemiapodcast Vielen lieben Dank an @florian_krammer, @CorneliaBetsch, @Karl_Lauterbach, @NatalieGrams und Sidney Chalhoub, die sich alle viel Zeit genommen haben, um mit uns für die Folge zu sprechen.
@pandemiapodcast @florian_krammer @CorneliaBetsch @Karl_Lauterbach @NatalieGrams Und vielen Dank auch an die Klaus-Tschira-Stiftung, die uns in dieser Staffel einige Folgen lang unterstützt, und natürlich die @riffreporter. Dort ist die Folge natürlich auch abrufbar:
riffreporter.de/corona-virus/p…

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Kai Kupferschmidt

Kai Kupferschmidt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kakape

Kai Kupferschmidt Profile picture
20 Dec
There’s a lot of concern and confusion right now about the new #sarscov2 variant identified in UK. I’ve spent today and yesterday talking to a dozen people working on this. My story is here: sciencemag.org/news/2020/12/m…
Thread to come (may be long and slow)
There are a ton of things to explain, dozens of questions to discuss and I won’t be able to cover more than a tiny part here now. So three general things up front:
1. Expect more threads and stories on this from me
2. A lot of scientists are working on this. You can follow @firefoxx66, @arambaut, @K_G_Andersen, @GuptaR_lab, @pathogenomenick, @EvolveDotZoo, @jbloom_lab, @Tuliodna for starters.
Read 15 tweets
Kai Kupferschmidt Profile picture
19 Dec
“We urge governments throughout Europe to agree on clearly formulated common goals, coordinate their efforts, develop regionally adapted strategies to reach the goals, and thereby work resolutely towards low case numbers”, @CiesekSandra, @ViolaPriesemann and others in @TheLancet
The lack of a European strategy is something scientists and public health experts have pointed out again and again and it’s good to see it clearly formulated by a group of prominent researchers thelancet.com/journals/lance…
The authors also give a good, succinct summary of arguments for going for low #covid19 case numbers:
1. saving lives
2. saving the economy
3. control is more effective
4. makes TTI feasible
5. natural acquired herd immunity is not an option
6. no need for rapid policy changes
Read 4 tweets
Kai Kupferschmidt Profile picture
18 Dec
Global vaccine news: COVAX says deals are in place to access nearly 2 billion doses of #covid19 vaccine. "For the vast majority of these deals, COVAX has guaranteed access to a portion of the first wave of production, followed by volume scales as further supply becomes available”
The new deals include:
- an advance purchase agreement with AstraZeneca for 170 million doses of the AstraZeneca/Oxford candidate
- a memorandum of understanding (MoU) with Johnson & Johnson for 500 million doses of the Janssen candidate (investigated as single dose vaccine)
That’s on top of:
- agreement with Serum Institute of India for 200 million doses (plus option for 900 million more doses) of either AZ or Novavax vaccine
- statement of intent for 200 million doses of Sanofi/GSK vaccine candidate
Read 12 tweets
Kai Kupferschmidt Profile picture
18 Dec
Science asked me to -briefly- reflect on what happened in 2020. So, a thread on this year in science, the breakthroughs and breakdowns and where my head is at at the end of this difficult year.

Story is here:
vis.sciencemag.org/breakthrough20…
First, read @sciencecohen's beautiful, personal story on the vaccines:

“I can stop worrying about my mom dying alone in an intensive care unit, away from all who love her. And she can stop asking whether I’ll let her play mahjong with the girls”

vis.sciencemag.org/breakthrough20…
@sciencecohen The rapid development of efficacious #covid19 vaccines was clearly the science breakthrough of the year. But what about all the rest that went on in #covid19 science? My story is labeled “breakdown”, but the picture is complicated.
Read 18 tweets
Kai Kupferschmidt Profile picture
17 Dec
Expected, but still good #covid19 vaccine news for Europe: @EMA_News has now moved up the likely date for Moderna vaccine as well. Meeting now scheduled for January 6 instead of January 12. Means vaccination with second vaccine likely to start a week earlier than thought in EU.
@EMA_News "Today, ahead of schedule, the company has submitted the last outstanding data package needed for the assessment of the application. This contains information that is specific to the manufacturing of the vaccine for the EU market“, says EMA press release.
@EMA_News "The number of infections is increasing across Europe and we are aware of the huge responsibility we have to get a vaccine to the market as quickly as is feasible, whilst maintaining the robustness of our scientific review”, EMA head Emer Cooke says in the press release.
Read 4 tweets
Kai Kupferschmidt Profile picture
15 Dec
Big news for Europe: @EMA_News now planning to meet on 21 December not 29 to conclude assessment of Pfizer/Biontech #covid19 vaccine and hopefully recommend conditional marketing authorisation.
@EMA_News "Following receipt yesterday evening of additional data requested by the CHMP from the company and pending the outcome of its evaluation, an exceptional meeting of the CHMP has now been scheduled for 21 December to conclude if possible”, says press statement they just e-mailed.
@EMA_News That means the timeline for vaccinations across Europe is likely moving up by about a week.
Not surprised to see this given growing chorus of voices in recent days asking why Europe is taking longer than UK/US.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

Like this author's thread?

Get emails when @kakape has new unrolls!

Check out other threads from @kakape!

Read all threads by @kakape